• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SpliceAid 2:一个人类剪接因子表达数据和 RNA 靶标基序数据库。

SpliceAid 2: a database of human splicing factors expression data and RNA target motifs.

机构信息

Department of Specialized Clinical Sciences and Odontostomatology, Polytechnic University of Marche, Ancona, Italy.

出版信息

Hum Mutat. 2012 Jan;33(1):81-5. doi: 10.1002/humu.21609. Epub 2011 Oct 17.

DOI:10.1002/humu.21609
PMID:21922594
Abstract

Splicing is the most frequently altered biological process by mutations within gene regions. Information for splicing is recognized by several factors that bind pre-mRNA sequence and, through coordinated interaction, yield mature transcripts. Some in silico methods have been developed to predict if a mutation leads to aberrant splicing patterns. We previously created SpliceAid tool that is able to minimize false positive predictions because it adopts strictly experimental RNA target motifs bound by splicing proteins in humans. In order to improve prediction accuracy and better understand the splicing outcome, the tissue specificity of each splicing regulatory factor has to be taken into account. Here, we have developed SpliceAid 2 by adding the expression data related to the splicing factors extracted from the main proteomic and transcriptomic databases, true 5' and 3' splice sites, polypyrimidine tracts, and branch point sequences. The new version collects 2,220 target sites of 62 human splicing proteins and their expression data in 320 tissues per cell. SpliceAid 2 can be useful to foresee the splicing pattern alteration, to guide the identification of the molecular effect due to the mutations and to understand the tissue-specific alternative splicing. SpliceAid 2 is freely accessible at www.introni.it/spliceaid.html.

摘要

剪接是基因区域内突变最常改变的生物过程。剪接的信息由几个结合前体 mRNA 序列的因子识别,通过协调相互作用,产生成熟的转录物。已经开发了一些计算方法来预测突变是否导致异常剪接模式。我们之前创建了 SpliceAid 工具,它能够最小化假阳性预测,因为它采用了严格的实验 RNA 靶标模式,这些模式由人类剪接蛋白结合。为了提高预测准确性并更好地理解剪接结果,必须考虑每个剪接调节因子的组织特异性。在这里,我们通过添加与从主要蛋白质组学和转录组学数据库中提取的剪接因子相关的表达数据、真实的 5' 和 3' 剪接位点、多嘧啶序列和分支点序列,开发了 SpliceAid 2。新版本收集了 62 个人类剪接蛋白的 2,220 个靶标位点及其在 320 种细胞组织中的表达数据。SpliceAid 2 可用于预测剪接模式的改变,指导因突变而导致的分子效应的识别,并理解组织特异性的可变剪接。SpliceAid 2 可在 www.introni.it/spliceaid.html 上免费获得。

相似文献

1
SpliceAid 2: a database of human splicing factors expression data and RNA target motifs.SpliceAid 2:一个人类剪接因子表达数据和 RNA 靶标基序数据库。
Hum Mutat. 2012 Jan;33(1):81-5. doi: 10.1002/humu.21609. Epub 2011 Oct 17.
2
SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans.SpliceAid:一个关于人类中与剪接蛋白结合的实验性RNA靶基序的数据库。
Bioinformatics. 2009 May 1;25(9):1211-3. doi: 10.1093/bioinformatics/btp124. Epub 2009 Mar 4.
3
In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.MLH1和MSH2错义突变的计算机模拟和体内剪接分析显示了外显子和组织特异性效应。
BMC Genomics. 2006 Sep 22;7:243. doi: 10.1186/1471-2164-7-243.
4
SpliceAid-F: a database of human splicing factors and their RNA-binding sites.SpliceAid-F:一个人类剪接因子及其 RNA 结合位点数据库。
Nucleic Acids Res. 2013 Jan;41(Database issue):D125-31. doi: 10.1093/nar/gks997. Epub 2012 Oct 30.
5
Ultra-deep sequencing reveals pre-mRNA splicing as a sequence driven high-fidelity process.超深度测序揭示了前体 mRNA 剪接作为一个序列驱动的高保真过程。
PLoS One. 2019 Oct 3;14(10):e0223132. doi: 10.1371/journal.pone.0223132. eCollection 2019.
6
Sequence information for the splicing of human pre-mRNA identified by support vector machine classification.通过支持向量机分类确定的人类前体mRNA剪接的序列信息。
Genome Res. 2003 Dec;13(12):2637-50. doi: 10.1101/gr.1679003.
7
Evolutionarily emerged G tracts between the polypyrimidine tract and 3' AG are splicing silencers enriched in genes involved in cancer.在多嘧啶序列和3'端AG之间进化产生的G序列是富含癌症相关基因的剪接沉默子。
BMC Genomics. 2014 Dec 19;15(1):1143. doi: 10.1186/1471-2164-15-1143.
8
Searching for splicing motifs.寻找剪接基序。
Adv Exp Med Biol. 2007;623:85-106. doi: 10.1007/978-0-387-77374-2_6.
9
Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.读取-分割-运行:一种利用RNA测序数据识别全基因组非经典剪接区域的改进型生物信息学流程。
BMC Genomics. 2016 Aug 22;17 Suppl 7(Suppl 7):503. doi: 10.1186/s12864-016-2896-7.
10
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.低密度脂蛋白受体(LDLR)基因内含子突变对前体mRNA剪接的影响:湿实验室分析与生物信息学分析的比较
Mol Genet Metab. 2009 Apr;96(4):245-52. doi: 10.1016/j.ymgme.2008.12.014. Epub 2009 Feb 10.

引用本文的文献

1
SPAT inhibits LUAD metastasis by targeting SF1-mediated splicing.SPAT通过靶向SF1介导的剪接抑制肺腺癌转移。
Cell Death Dis. 2025 Aug 8;16(1):598. doi: 10.1038/s41419-025-07924-2.
2
A Preliminary Association Study of H19 Non-Coding Gene Variants With Risk of Non-Hodgkin Lymphoma: A Case-Control Study and Computational Analysis.H19非编码基因变异与非霍奇金淋巴瘤风险的初步关联研究:一项病例对照研究及计算分析
J Clin Lab Anal. 2025 Jun;39(11):e70024. doi: 10.1002/jcla.70024. Epub 2025 May 16.
3
Comprehensive systems biology analysis reveals splicing factor contributions to cutaneous melanoma progression.
综合系统生物学分析揭示剪接因子对皮肤黑色素瘤进展的作用。
Sci Rep. 2025 Mar 19;15(1):9486. doi: 10.1038/s41598-025-93695-x.
4
Data-driven insights to inform splice-altering variant assessment.基于数据的见解为剪接改变变异评估提供信息。
Am J Hum Genet. 2025 Apr 3;112(4):764-778. doi: 10.1016/j.ajhg.2025.02.012. Epub 2025 Mar 7.
5
Unraveling the Role of Cathepsin B Variants in Polycystic Ovary Syndrome: Insights from a Case-Control Study and Computational Analyses.解析组织蛋白酶B变体在多囊卵巢综合征中的作用:病例对照研究及计算分析的见解
Reprod Sci. 2025 Apr;32(4):1166-1179. doi: 10.1007/s43032-025-01806-w. Epub 2025 Mar 5.
6
Difference Analysis Among Six Kinds of Acceptor Splicing Sequences by the Dispersion Features of 6-mer Subsets in Human Genes.基于人类基因中六聚体子集的离散特征对六种受体剪接序列的差异分析
Biology (Basel). 2025 Feb 15;14(2):206. doi: 10.3390/biology14020206.
7
Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme.建立可变剪接预后风险模型并鉴定纤连蛋白1(FN1)作为多形性胶质母细胞瘤的潜在生物标志物。
Sci Rep. 2025 Feb 25;15(1):6716. doi: 10.1038/s41598-025-91038-4.
8
New Genetic Variations in RNA-binding Protein Gene and Breast Cancer Risk: A Case-Control Study.RNA结合蛋白基因的新遗传变异与乳腺癌风险:一项病例对照研究。
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):137-145. doi: 10.31557/APJCP.2025.26.1.137.
9
Uplift of genetic diagnosis of rare respiratory disease using airway epithelium transcriptome analysis.利用气道上皮转录组分析提升罕见呼吸道疾病的基因诊断水平
Hum Mol Genet. 2025 Jan 29;34(2):148-160. doi: 10.1093/hmg/ddae164.
10
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.靶向前列腺癌中的CLK2/SRSF9剪接轴可导致ARV7表达降低。
Mol Oncol. 2025 Feb;19(2):496-518. doi: 10.1002/1878-0261.13728. Epub 2024 Sep 11.